Main > PSYCHIATRY > Pediatrics > Attention Deficit HyperAc. Disorder > Treatment > Central Nervous System Stimulants > Amphetamine. > Co.: USA. N (Phase III/Patent) > Patent
Patent's subsections
Assignee, Claims, No., Etc.
Total No. of U.S. Patents: 1
UpDate: 10.17.06
US Expiration Date: 06.01.2024
Patent's products
This section has no products